US 7700274
Compositions and methods in cancer associated with altered expression of KCNJ9
granted A61KA61K2039/53A61K38/00
Quick answer
US patent 7700274 (Compositions and methods in cancer associated with altered expression of KCNJ9) held by Sagres Discovery, Inc. expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sagres Discovery, Inc.
- Grant date
- Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/53, A61K38/00, A61P, A61P35/00